Remeditex Ventures LLC's Net Worth
$208 Million
Who is Remeditex Ventures LLC?
Remeditex Ventures LLC has an estimated net worth of $208 Million. This is based on reported shares across multiple companies, which include Viridian Therapeutics, Inc.\DE, LPATH, INC, Soliton, Inc., Menlo Therapeutics Inc., and BELLICUM PHARMACEUTICALS, INC.
SEC CIK
Remeditex Ventures LLC's CIK is 0001627363
Past Insider Trading and Trends
2014 was Remeditex Ventures LLC's most active year for acquiring shares with 5 total transactions. Remeditex Ventures LLC's most active month to acquire stocks was the month of November. 2014 was Remeditex Ventures LLC's most active year for disposing of shares, totalling 4 transactions. Remeditex Ventures LLC's most active month to dispose stocks was the month of November. 2020 saw Remeditex Ventures LLC paying a total of $999,992.30 for 120,481 shares, this is the most they've acquired in one year. In 2021 Remeditex Ventures LLC cashed out on 9,635,085 shares for a total of $208,242,660.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $14.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LPATH, INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.31M |
—
|
—
| 1.31M |
Dec 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Soliton, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.21M |
$22.60 | -$208,242,660.20 |
0
|
Dec 16
| |||
Form 4
| +1.32% | 120.48K |
$8.30 | $999,992.30 | 9.21M |
Jun 30
| |||
Form 4
| +1.74% | 155.28K |
—
|
—
| 9.09M |
Oct 11
| |||
Form 4
| +4.16% | 357.14K |
—
|
—
| 8.94M |
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Menlo Therapeutics Inc. (VYNE) Snapshot price: $1.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BELLICUM PHARMACEUTICALS, INC (BLCM) Snapshot price: $0.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.81M |
—
|
—
| 1.81M |
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||